Here's what to expect: Typical Semaglutide Titration: Weeks 1-4: 0.25 mg weekly (lowest dose) Weeks 5-8: 0.5 mg weekly Weeks 9-12: 1.0 mg weekly Weeks 13-16: 1.7 mg weekly Week 17+: 2.4 mg weekly (maintenance) Typical Tirzepatide Titration: Weeks 1-4: 2.5 mg weekly Weeks 5-8: 5 mg weekly Weeks 9-12: 7.5 mg weekly Weeks 13-16: 10 mg weekly Weeks 17-20: 12.5 mg weekly Week 21+: 15 mg weekly (maintenance) You'll have a nurse check-in at each dose adjustment to monitor tolerability, appetite suppression, weight change, and side effects
Four study centers serving HIV-infected patients in the USA were selected
Manuscript source: Unsolicited manuscript Peer-review started: October 11, 2019 First decision: November 2, 2019 Article in press: February 17, 2020 Specialty type: Gastroenterology and hepatology Country/Territory of origin: United States Peer-review reports scientific quality classification Grade A (Excellent): A Grade B (Very good): B Grade C (Good): C, C Grade D (Fair): 0 Grade E (Poor): 0 P-Reviewer: Cure E, De Ponti F, Lei YC, Qadir MI S-Editor: Wang YQ L-Editor: A E-Editor: Wu YXJ Contributor Information Laura Rotundo, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, United States
Each patient is different, and we formulate a unique concentration for your skin based upon careful examination
(PubMed) Hutto BR